Michael Bax

Buffalo Spree Top Doctor 2024

Dr. Bax is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.

Top Doctors 2024

Cancers Treated:

Specializing In:

Mohs micrographic surgery for basal cell carcinoma and squamous cell carcinoma Modified Mohs micrographic surgery (overnight permanent sections for 100% peripheral margin control) for melanoma and other rare cutaneous malignancies Excision of benign, pre-malignant, and malignant tumors of the skin

About Michael Bax


Roswell Park Comprehensive Cancer Center
  • Assistant Professor of Oncology
  • Department of Dermatology


Education and Training:

  • 2011 – MD – State University of New York Upstate Medical University, Syracuse, NY


  • 2015 - University of Rochester, School of Medicine and Dentistry, Rochester, NY
  • 2013 – Dermatology –State University of New York at Buffalo, School of Medicine and Biomedical Sciences


  • 2016 – Micrographic Surgery and Dermatologic Oncology - University of Michigan Health Systems, Ann Arbor, MI

Board Certification:

  • American Board of Dermatology

Professional Memberships:

  • American Academy of Dermatology
  • American College of Mohs Surgery
  • American Society of Dermatologic Surgery

Honors & Awards:

  • 2015 - Beutner Immunodermatology Resident Scholar Award
  • 2014 - American Society of Dermatologic Surgery Preceptorship Program Award
  • 2014 - American Society of Laser Medicine and Surgery Preceptorship Program Award
  • 2013 - American Society of Dermatologic Surgery Resident Scholarship Award

Featured on Cancer Talk


  • Bax D, Bax M, Pokharel S, Bogner PN. Pilomatricoma of the scalp mimicking poorly differentiated cutaneous carcinoma on positron emission tomography/computed tomography (PET/CT) scan and fine-needle aspiration (FNA) cytology. JAAD Case Rep. 2018 Apr 30;4(5):446-448. doi: 10.1016/j.jdcr.2017.12.006. PMID: 29984278; PMCID: PMC6031568.
  • Helm MM, Grassi M, Bax MJ. Pseudoepitheliomatous Hyperplasia in the Setting of CD30+ Lymphoproliferative Disease: A Histologic Mimic of Squamous Cell Carcinoma that Exhibits Indolent Clinical Behavior. Int J Clin Dermatol Res. 2017;5(7):151-153. doi: 10.19070/2332-2977-1700034.
  • Bax MJ, Brown MD, Rothberg PG, Laughlin TS, Scott GA. Pigmented Epithelioid Melanocytoma (Animal Type Melanoma): An Institutional Experience. J Am Acad Dermatol. 2017 Aug;77(2):328-332.
  • Helm MF, Bax MJ, Augenblick DJ, Chung CG. Melanoma in situ of lentigo maligna type in a young woman. Int J Dermatol. Int J Dermatol. 2017 Sep;56(9):961-962. doi: 10.1111/ijd.13636. Epub 2017 Apr 23. PMID: 28436025.
  • Helm MF, Bax MJ, Bogner PN, Chung CG. Metastatic melanoma with features of blue nevus and tumoral melanosis identified during pembrolizumab therapy. JAAD Case Rep. 2017 Mar 15;3(2):135-137. doi: 10.1016/j.jdcr.2017.01.019. PMID: 28367487; PMCID: PMC5361860.
  • Bax MJ, Johnson TM, Harms PW, Schwartz JL, Zhao L, Fullen DR, Chan MP. Detection of Occult Invasion in Melanoma In Situ. JAMA Dermatol. 2016 Nov 1;152(11):1201-1208. doi: 10.1001/jamadermatol.2016.2668. PMID: 27533878.